Cencora INC CENCORA INC ORD SHS
Cencora INC CENCORA INC ORD SHS/ US03073E1055 /
0HF3
|
2024-04-10 12:00:00 AM
|
Chg.
-
|
Volume |
Bid6:00:05 AM |
Ask6:00:05 AM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
240.16USD
|
-
|
391
Turnover: - |
-Bid Size: - |
-Ask Size: - |
48.35 bill.USD |
0.79% |
28.47 |
Business description
Cencora, formerly known as AmerisourceBergen, is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, Cencora delivers innovative programs and solutions across the pharmaceutical supply channel in human and animal health.
Management board & Supervisory board
| CEO |
| Steven H. Collis |
| Management board |
| James F. Cleary, Jr., Elizabeth S. Campbell, Gina K. Clark, Kourosh Q. Pirouz, Lazarus Krikorian, Leslie E. Donato, Robert P. Mauch, Silvana Battaglia, Jennifer Dubas |
| Supervisory board |
| Steven H. Collis, D. Mark Durcan, Dennis M. Nally, Henry W. McGee, Kathleen W. Hyle, Lon R. Greenberg, Ornella Barra, Richard W. Gochnauer, Redonda Miller, Lorence H. Kim, M.D. |
Company data
| Name: |
Cencora Inc |
| Address: |
1 West First Avenue,Conshohocken, PA 19428-1800, USA |
| Phone: |
+1-610-727-7000 |
| Fax: |
+1-800-640-5221 |
| E-mail: |
InvestorRelations@cencora.com
|
| Internet: |
https://www.cencora.com/ |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
Pharmaceuticals |
| End of financial year: |
09-30 |
| Free Float: |
55.10% |
| IPO date: |
1995-04-04 |
